ADD2
Beta-adducin
Also known as: ADDB, ADDB_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- P35612
- Gene
- ADD2
- Ensembl
- ENSG00000075340
- Chromosome
- 2
- Canonical length
- 726 aa
- Protein class
- Predicted intracellular proteins
- Subcellular location
- Nucleoplasm,Plasma membrane,Cytosol
OverviewNCBI Gene
Adducins are heteromeric proteins composed of different subunits referred to as adducin alpha, beta and gamma. The three subunits are encoded by distinct genes and belong to a family of membrane skeletal proteins involved in the assembly of spectrin-actin network in erythrocytes and at sites of cell-cell contact in epithelial tissues. While adducins alpha and gamma are ubiquitously expressed, the expression of adducin beta is restricted to brain and hematopoietic tissues. Adducin, originally purified from human erythrocytes, was found to be a heterodimer of adducins alpha and beta. Polymorphisms resulting in amino acid substitutions in these two subunits have been associated with the regulation of blood pressure in an animal model of hypertension. Heterodimers consisting of alpha and gamma subunits have also been described. Structurally, each subunit is comprised of two distinct domains. The amino-terminal region is protease resistant and globular in shape, while the carboxy-terminal region is protease sensitive. The latter contains multiple phosphorylation sites for protein kinase C, the binding site for calmodulin, and is required for association with spectrin and actin. Alternatively spliced transcript variants have been described. [provided by RefSeq, Jun 2010]
Canonical amino-acid sequenceUniProt
726 residues, UniProt reviewed canonical sequence.
>P35612|ADD2
1 MSEETVPEAA SPPPPQGQPY FDRFSEDDPE YMRLRNRAAD LRQDFNLMEQ KKRVTMILQS
61 PSFREELEGL IQEQMKKGNN SSNIWALRQI ADFMASTSHA VFPTSSMNVS MMTPINDLHT
121 ADSLNLAKGE RLMRCKISSV YRLLDLYGWA QLSDTYVTLR VSKEQDHFLI SPKGVSCSEV
181 TASSLIKVNI LGEVVEKGSS CFPVDTTGFC LHSAIYAARP DVRCIIHLHT PATAAVSAMK
241 WGLLPVSHNA LLVGDMAYYD FNGEMEQEAD RINLQKCLGP TCKILVLRNH GVVALGDTVE
301 EAFYKIFHLQ AACEIQVSAL SSAGGVENLI LLEQEKHRPH EVGSVQWAGS TFGPMQKSRL
361 GEHEFEALMR MLDNLGYRTG YTYRHPFVQE KTKHKSEVEI PATVTAFVFE EDGAPVPALR
421 QHAQKQQKEK TRWLNTPNTY LRVNVADEVQ RSMGSPRPKT TWMKADEVEK SSSGMPIRIE
481 NPNQFVPLYT DPQEVLEMRN KIREQNRQDV KSAGPQSQLL ASVIAEKSRS PSTESQLMSK
541 GDEDTKDDSE ETVPNPFSQL TDQELEEYKK EVERKKLELD GEKETAPEEP GSPAKSAPAS
601 PVQSPAKEAE TKSPLVSPSK SLEEGTKKTE TSKAATTEPE TTQPEGVVVN GREEEQTAEE
661 ILSKGLSQMT TSADTDVDTS KDKTESVTSG PMSPEGSPSK SPSKKKKKFR TPSFLKKSKK
721 KEKVESLocalizationUniProt · AlphaFold · HPA
Whether an antibody against ADD2 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Cell surface
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.49
- Highest tissue expression
- 63 nTPM
Expression across tissuesHPA
Tissue
- bone marrow: 63 nTPM
- cerebellum: 36 nTPM
- cerebral cortex: 25 nTPM
- basal ganglia: 17 nTPM
- retina: 15 nTPM
- hippocampal formation: 13 nTPM
Single-cell type
- retinal horizontal cells: 421 nCPM
- erythrocyte progenitors: 247 nCPM
- retinal ganglion cells: 232 nCPM
- brain excitatory neurons: 162 nCPM
- brain inhibitory neurons: 124 nCPM
- late spermatids: 91 nCPM
Immune cell
- memory B-cell: 2.3 nTPM
- non-classical monocyte: 2.3 nTPM
- naive B-cell: 1.7 nTPM
- intermediate monocyte: 1.2 nTPM
- naive CD4 T-cell: 0.8 nTPM
- naive CD8 T-cell: 0.4 nTPM
Brain region
- cerebral cortex: 203 nTPM
- basal ganglia: 130 nTPM
- cerebellum: 121 nTPM
- pons: 117 nTPM
- white matter: 113 nTPM
- hypothalamus: 105 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.27
- gnomAD pLI
- 1
- gnomAD missense Z
- 2.1
- DepMap mean gene effect
- 0.01
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 5% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- actin cytoskeleton organization
- actin filament bundle assembly
- barbed-end actin filament capping
- hemopoiesis
- leukocyte migration
- leukocyte tethering or rolling
- protein-containing complex assembly
- synapse assembly
Molecular functions
- actin binding
- actin filament binding
- calmodulin binding
- cytoskeletal anchor activity
- protein dimerization activity
- protein heterodimerization activity
- protein homodimerization activity
- protein kinase binding
- spectrin binding
- structural constituent of cytoskeleton
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of ADD2 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads ADD2 as an antibody target. Whether an autoantibody or antibody against ADD2 could matter depends on whether native ADD2 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
ADD2 is annotated at the cell surface, where native ADD2 is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.
Annotation status
The present source text does not explicitly label ADD2 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...